Dapsone Tablet
Product Images NDC 51672-4197

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 51672-4197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dapsone 01)

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
This is a description of a medication containing 100mg Dapsore available in 30 tablets. The medication is manufactured by Taro Pharmaceuticals Industries Limited and distributed by Taro Pharmaceuticals U.S.A., Inc. It should be dispensed in a locked, light-resistant container and stored at controlled room temperature. The usual dosage and prescribing information are available in the package insert. The product should be kept out of reach of children. The text also includes product codes and a registered trademark.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.